A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/44 (2006.01) A61K 31/415 (2006.01) A61K 31/4439 (2006.01)
Patent
CA 2257405
A new administration regimen giving an extended plasma concentration profile of a H+, K+-ATPase inhibitor. The extended plasma profile is received by two or more consecutive administrations of a unit dose of a H+, K+-ATPase with 0.5- 4 hours interval or by a pharmaceutical composition with extended release, which may be administered once daily.
Nouveau régime d'administration produisant un profil de concentration de plasma étendu d'un inhibiteur de H?+¿, K?+¿-ATPase. Le profil de plasma étendu est reçu par deux ou plusieurs administrations consécutives d'une dose unitaire d'une H?+¿, K?+¿-ATPase avec un intervalle de 0,5 à 4 heures ou par une composition pharmaceutique avec libération prolongée et pouvant être administrée une fois par jour.
Cederberg Christer
Sachs George
Astra Aktiebolag
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
Administration regimen of h+, k+-atpase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Administration regimen of h+, k+-atpase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Administration regimen of h+, k+-atpase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2043123